TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioaxter Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
466 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
-46
|
243
|
16 |
| EBITDA |
-36
|
253
|
126 |
| Total assets |
214
|
272
|
270 |
| Current assets |
201
|
248
|
158 |
| Current liabilities |
7
|
14
|
109 |
| Equity capital |
207
|
257
|
145 |
| - share capital |
5
|
5
|
5 |
| Employees (average) |
1
|
1
|
4 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
96.7%
|
94.5%
|
53.7% |
| Turnover per employee |
0
|
0
|
116 |
| Profit as a percentage of turnover | 3.4% | ||
| Return on assets (ROA) |
-21.5%
|
89.3%
|
6.3% |
| Current ratio |
2871.4%
|
1771.4%
|
145.0% |
| Return on equity (ROE) |
-22.2%
|
94.6%
|
11.0% |
| Change turnover |
0
|
-484
|
-50 |
| Change turnover % |
-100%
|
-10% | |
| Chg. No. of employees |
0
|
-3
|
0 |
| Chg. No. of employees % |
0%
|
-75%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.